Browsing by Author Hodgson, L

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 5 to 9 of 9 < previous 
TitleAuthor(s)Issue DateViews
 
Phase II study of dasatinib in patients with previously treated malignant mesothelioma (Cancer and leukemia group B 30601): A brief report
Journal:Journal of Thoracic Oncology
Dudek, AZPang, HKratzke, RAOtterson, GAHodgson, LVokes, EEKindler, HL
2012
49
 
Phase II study of the histone deacetylase inhibitor Romidepsin in relapsed small cell lung cancer (Cancer and Leukemia Group B 30304)
Journal:Journal of Thoracic Oncology
Otterson, GAHodgson, LPang, HVokes, EE
2010
54
 
Predictors of pulmonary toxicity in limited stage small cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70Gy daily radiotherapy: CALGB 30904
Journal:Lung Cancer
Salama, JKPang, HBogart, JABlackstock, AWUrbanic, JJHodgson, LCrawford, JVokes, EE
2013
42
 
Predictors of pulmonary toxicity in limited-stage (LS) small cell lung cancer (SCLC) patients treated with concurrent chemotherapy (CTX) and high-dose (70 Gy) daily radiotherapy (RT): a pooled analysis of three CALGB studies
Proceeding/Conference:Journal of Clinical Oncology
Salama, JKHodgson, LPang, HMH
2011
63
 
Validation of Progression‐Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials
Journal:The Oncologist
Wang, XWang, XYHodgson, LGeorge, SSargent, DFoster, NGanti, AStinchcombe, TCrawford, JKratzke, RAdjei, AKindler, HVokes, EPang, HMH
2017
42
Showing results 5 to 9 of 9 < previous